首页> 外文期刊>Food Chemistry >A single acute dose of pinitol from a naturally-occurring food ingredient decreases hyperglycaemia and circulating insulin levels in healthy subjects
【24h】

A single acute dose of pinitol from a naturally-occurring food ingredient decreases hyperglycaemia and circulating insulin levels in healthy subjects

机译:来自自然食品成分的单一剂量的松果糖醇可降低健康受试者的高血糖症和循环胰岛素水平

获取原文
获取原文并翻译 | 示例
       

摘要

A limited amount of research suggests that oral ingestion of pinitol (3-0-methyl-D-chiro-inositol) positively influences glucose tolerance in humans. This study assessed the effects of different doses of pinitol supplementation on glucose tolerance, insulin sensitivity and plasma pinitol concentrations. Thirty healthy subjects underwent two one-day trials in which they consumed a nutritive beverage (Fruit Up~®) containing 2.5,4.0 or 6.0 g of pinitol and a corresponding placebo equivalent in both energy and carbohydrates. Blood samples were collected frequently over the 240-min test period. The pinitol-enriched beverage reduced serum glucose and insulin at 45 and 60 min, but only at a dose of 6.0 g. Plasma pinitol concentrations, maximum concentration and AUC increased according to the dose administered. The results show that a single dose of pinitol from a naturally-occurring food ingredient at the highest dose administered acutely influences indices of whole-body glucose tolerance and insulin sensitivity in healthy subjects.
机译:有限的研究表明,口服摄入松子醇(3-0-甲基-D-手性肌醇)可对人的葡萄糖耐量产生积极影响。这项研究评估了不同剂量的松醇的补充对葡萄糖耐量,胰岛素敏感性和血浆松醇浓度的影响。 30名健康受试者接受了两个为期一天的试验,他们食用了一种营养饮料(FruitUp®),其中含有2.5、4.0或6.0 g的松醇,以及相应的安慰剂,其能量和碳水化合物均相当。在240分钟的测试期间内经常采集血液样本。富含pin糖醇的饮料在45和60分钟时降低了血清葡萄糖和胰岛素,但仅以6.0 g的剂量降低了。血浆松露醇浓度,最大浓度和AUC随给药剂量的增加而增加。结果表明,以最高剂量服用天然食物成分中的单一剂量的松醇,会严重影响健康受试者的全身葡萄糖耐量指数和胰岛素敏感性指数。

著录项

  • 来源
    《Food Chemistry》 |2013年第2期|1267-1272|共6页
  • 作者单位

    Service of Endocrinology, University Hospital Dr. Peset,Av Gaspar Aguilar 90, 46017 Valencia, Spain,Department of Medicine, Faculty of Medicine, University of Valencia, Av Blasco Ibanez 13, 46010 Valencia, Spain,Foundation for the Promotion of Healthcare and Biomedical Research in the Valencian Community (F1SABIO), C/ San Lazaro s, 46017 Valencia, Spain,Institute of Health Research INCLIVA, Av Blasco Ibanez 17, 46010 Valencia, Spain;

    Service of Endocrinology, University Hospital Dr. Peset,Av Gaspar Aguilar 90, 46017 Valencia, Spain,Department of Medicine, Faculty of Medicine, University of Valencia, Av Blasco Ibanez 13, 46010 Valencia, Spain,Institute of Health Research INCLIVA, Av Blasco Ibanez 17, 46010 Valencia, Spain;

    Department of Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy, University of Valencia, Av. Vicente Andres Estelles s, 46100 Burjasot, Spain;

    Service of Endocrinology, University Hospital Dr. Peset,Av Gaspar Aguilar 90, 46017 Valencia, Spain,Department of Medicine, Faculty of Medicine, University of Valencia, Av Blasco Ibanez 13, 46010 Valencia, Spain;

    Service of Endocrinology, University Hospital Dr. Peset,Av Gaspar Aguilar 90, 46017 Valencia, Spain,Department of Medicine, Faculty of Medicine, University of Valencia, Av Blasco Ibanez 13, 46010 Valencia, Spain;

    Service of Endocrinology, University Hospital Dr. Peset,Av Gaspar Aguilar 90, 46017 Valencia, Spain,Foundation for the Promotion of Healthcare and Biomedical Research in the Valencian Community (F1SABIO), C/ San Lazaro s, 46017 Valencia, Spain,Institute of Health Research INCLIVA, Av Blasco Ibanez 17, 46010 Valencia, Spain;

    Service of Endocrinology, University Hospital Dr. Peset,Av Gaspar Aguilar 90, 46017 Valencia, Spain,Foundation for the Promotion of Healthcare and Biomedical Research in the Valencian Community (F1SABIO), C/ San Lazaro s, 46017 Valencia, Spain,Institute of Health Research INCLIVA, Av Blasco Ibanez 17, 46010 Valencia, Spain,CIBER CB06/04/0071 Research Group, CIBER Hepatic and Digestive Diseases, University of Valencia, Av Blasco Ibanez 13, 46010 Valencia, Spain;

    Service of Endocrinology, University Hospital Dr. Peset,Av Gaspar Aguilar 90, 46017 Valencia, Spain,Foundation for the Promotion of Healthcare and Biomedical Research in the Valencian Community (F1SABIO), C/ San Lazaro s, 46017 Valencia, Spain,Institute of Health Research INCLIVA, Av Blasco Ibanez 17, 46010 Valencia, Spain,CIBER CB06/04/0071 Research Group, CIBER Hepatic and Digestive Diseases, University of Valencia, Av Blasco Ibanez 13, 46010 Valencia, Spain;

  • 收录信息 美国《科学引文索引》(SCI);美国《生物学医学文摘》(MEDLINE);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

    Glycaemia; Human; Insulin sensitivity; Pinitol;

    机译:血糖人类胰岛素敏感性;松醇;
  • 入库时间 2022-08-17 23:22:10

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号